Enzium
About:
Enzium develops fluorescent based reagents for selective protease.
Website: http://enziumlabs.com
Top Investors: BioAdvance
Description:
Enzium is dedicated to developing fluorescent based reagents for highly selective protease activity detection using their proprietary modular protein and dye technology. Their technology allows us to quickly swap out protein modules, much like legos, to easily build new, selective assay reagents. It is their goal to enable their customers to integrate the same reagent kit/assay in applications across entire research, drug, and diagnostic development pipelines.
$750000
Less than $1M
Philadelphia, Pennsylvania, United States
2011-01-01
info(AT)enziumlabs.com
Crystal Falco, Edan Yago, Peter Berget
1-10
2016-07-06
Private
© 2025 bioDAO.ai